Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $100 at Goldman Sachs

September 8, 2017 4:17 AM
Goldman Sachs raised its price target on Abbvie (NYSE: ABBV) to $100.00 (from $85.00) while maintaining a Buy rating.Analyst Jami ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments

Next Articles